Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea
· Delayed Price · Currency is KRW
11,440
-10 (-0.09%)
Nov 18, 2024, 3:19 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 263.27 billion as of November 18, 2024. Its market cap has decreased by -30.68% in one year.
Market Cap
263.27B
Enterprise Value
216.43B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
11,440.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 263.27B, an increase of 64.30%. That is a compound annual growth rate of 12.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 15, 2024 | 263.27B | -49.00% |
Dec 28, 2023 | 516.20B | -0.71% |
Dec 29, 2022 | 519.87B | -21.31% |
Dec 30, 2021 | 660.68B | -73.75% |
Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition